Feb 26, 2024, 07:53 AM by

Feb 26, 2024, 07:53 AM by

Feb 26, 2024, 07:53 AM by

Feb 26, 2024, 07:53 AM by

Sunbird Bio announced that new data from a study evaluating its APEX diagnostic platform in Alzheimer’s disease will be presented at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Disease, taking place March 5-9, 2024.

Feb 26, 2024, 07:53 AM by

Huateng Pharma offer Semaglutide Side Chain AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

Feb 26, 2024, 07:53 AM by

Nominations Open for DrFirst’s 2024 Healthiverse Heroes Award

Feb 26, 2024, 07:53 AM by

Drug discovery specialists Cresset have signed an international collaboration agreement with top global chemical building block providers Enamine to develop new drug discovery technology that can help identify viable drug candidates and unlock future treatment options.

Feb 26, 2024, 07:53 AM by

Lancet Digital Health Publishes Study Confirming MAGENTIQ-COLO™ AI-aided Colonoscopy Technology Improves Adenoma Detection Rates

Feb 23, 2024, 01:00 AM by User Not Found

Bio-IT World | In the race to unlock the power of artificial intelligence (AI) for business, it is tempting to focus on the need to strategically leverage data—indeed, this is a message that I reinforce constantly when onboarding new clients. But there’s a step that must happen first.

Feb 22, 2024, 08:23 AM by

Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.

Feb 22, 2024, 08:23 AM by

Feb 22, 2024, 08:23 AM by

TriLink’s CleanCap® Capping Technology is Patented Globally & TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs

Feb 22, 2024, 08:23 AM by

AES Clean Technology appoints new Vice President of Engineering  Montgomeryville, Pennsylvania, February 20th, 2024: AES Clean Technology, a leading provider of high-performance modular cleanroom facilities, has appointed Chris Barbieri as Vice President of Engineering. With over 20 years of experience in the life science industry and deep expertise in engineering and project delivery, Chris will oversee all aspects of engineering operations, including product development, innovation, and technological advancement initiatives that are aligned with AES’ strategic vision. In addition, he will focus on streamlining the team’s processes, driving consistency, and fostering a culture of technical excellence and innovation.

Feb 22, 2024, 01:00 AM by User Not Found

Bio-IT World | For roughly half of patients with recurrence of often-deadly glioblastoma multiforme (GBM), their tumors are characterized by cells that look a lot like healthy neurons. The mimicry trick was discovered by proteomics, which has opened a view to tumor alterations unavailable through genetics alone.

Feb 21, 2024, 06:14 AM by

Horizon CME has announced its sponsorship of the first annual summit for the multidisciplinary conference, Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer).

Feb 21, 2024, 06:14 AM by

ENPICOM has announced a collaboration with Erasmus Medical Center. This partnership aims to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.

Feb 20, 2024, 08:41 AM by

Feb 20, 2024, 08:41 AM by

The global digital biomarkers market showcased remarkable growth, reaching a valuation of USD 3.55 billion in 2023. Projections indicate an exponential trajectory, with expectations to soar to approximately USD 26.79 billion by 2033. This impressive growth is anticipated to occur at a robust compound annual growth rate (CAGR) of 22.4% during the forecast period spanning from 2024 to 2033.

Feb 20, 2024, 01:00 AM by User Not Found

Bio-IT World | More than a century has passed since the discovery of insulin, the world's first life-saving treatment for diabetes, and it is still being delivered via injection despite several brushes with success in developing an oral version of the drug. Hope is again on the horizon with the emergence of an oral nanotherapeutic formulation of insulin that comes with the possibility of reducing if not eliminating hypoglycemic events.

Feb 19, 2024, 08:39 AM by